AstraZeneca PLC ADR drops Thursday, underperforming market



[ad_1]

AstraZeneca PLC ADR AZN,
-1.41%
lost 1.41% to $ 50.19 on Thursday, in what turned out to be a great trading session for the stock market, with the NASDAQ Composite Index COMP,
+ 2.56%
up 2.56% to 13,067.48 and the Dow Jones Industrial Average DJIA index,
+ 0.69%
up 0.69% to 31,041.13. The fall of ADR ended a three-day streak. AstraZeneca PLC ADR closed $ 14.75 below its 52-week high ($ 64.94), which the company hit on July 20.

ADR underperformed some of its competitors on Thursday, such as AbbVie Inc. ABBV,
+ 1.07%
increased 1.07% to $ 106.71, Amgen Inc. AMGN,
+ 0.33%
rose 0.33% to $ 234.02 and Gilead Sciences Inc. GILD,
+ 0.92%
rose 0.92% to $ 62.52. Trade volume (13.6 M) eclipsed its 50-day average volume of 10.2 Mio.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

[ad_2]

Source link